Veterinary behavioral medicine has embraced pharmacology to treat conditions like separation anxiety, generalized anxiety, and compulsive disorders. Drugs such as selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine for dogs) and benzodiazepines are prescribed not as cures, but as tools to lower an animal’s emotional arousal enough for behavioral modification (desensitization and counter-conditioning) to work.
Crucially, the veterinarian must understand species-specific metabolism. For example, diazepam can cause fatal idiosyncratic hepatic necrosis in cats, and gabapentin is used for both neuropathic pain and anxiety in dogs and cats. Zoofilia Perro Abotona A Mujer Y Esta Llora Como Ni A
The most significant advancement is the recognition that behavior is a vital sign. Changes in activity, appetite, elimination, social interaction, and grooming are often the first indicators of underlying disease. For example, diazepam can cause fatal idiosyncratic hepatic
Veterinary science now employs SSRIs, TCAs, and even benzodiazepines for anxiety, compulsive disorders, and aggression. This bridges human and veterinary psychiatry, though off-label use and lack of species-specific pharmacokinetic data remain concerns. Veterinary science now employs SSRIs, TCAs, and even
The Fear Free initiative, founded by Dr. Marty Becker, is the most visible fruit of this union. Rooted in animal learning theory (behavior) and stress physiology (veterinary science), Fear Free protocols use gentle handling, pheromones (like Adaptil and Feliway), and pre-visit pharmaceuticals (e.g., gabapentin or trazodone) to reduce fear. The result? Lower cortisol levels, more accurate heart rates, and safer exams for both patient and practitioner.
The integration is robust in dogs, cats, and horses but lags for exotic pets, production animals, and wildlife.